The DOI matches its Crossref record; 454 of the 454 references it cites were found in a registry or an index.
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Open accessAbstract
G protein-coupled receptors (GPCRs), the largest family of human membrane proteins and an important class of drug targets, play a role in maintaining numerous physiological processes. Agonist or antagonist, orthosteric effects or allosteric effects, and biased signaling or balanced signaling, characterize the complexity of GPCR dynamic features. In this study, we first review the structural advancements, activation mechanisms, and functional diversity of GPCRs. We then focus on GPCR drug discovery by revealing the detailed drug-target interactions and the underlying mechanisms of orthosteric drugs approved by the US Food and Drug Administration in the past five years. Particularly, an up-to-date analysis is performed on available GPCR structures complexed with synthetic small-molecule allosteric modulators to elucidate key receptor-ligand interactions and allosteric mechanisms. Finally, we highlight how the widespread GPCR-druggable allosteric sites can guide structure- or mechanism-based drug design and propose prospects of designing bitopic ligands for the future therapeutic potential of targeting this receptor family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Avacopan for the Treatment of ANCA-Associated Vasculitis
Jayne, D. R. W., Merkel, P. A., Schall, T. J., & Bekker, P. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023386 · Cited by 1,021
RetractedHighly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Accurate prediction of protein structures and interactions using a 3-track network
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021) · doi:10.1101/2021.06.14.448402 · Cited by 5,549
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
The structure and function of G-protein-coupled receptors
Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534
Research works printed but not linked: 25
- Li, D. F. & Caffrey, M. Structure and functional characterization of membrane integral proteins in the lipid cubic phase. J. Mol. Biol. 432, 5104–5123 (2020). · doi:10.1016/j.jmb.2020.02.024
- Rubovitch, V., Gafni, M. & Sarne, Y. The mu opioid agonist DAMGO stimulates cAMP production in SK-N-SH cells through a PLC-PKC-Ca++ pathway. Mol. Brain Res. 110, 261–266 (2003). · doi:10.1016/s0169-328x(02)00656-3
- Hershberger, P. M. et al. Imidazole-derived agonists for the neurotensin 1 receptor. Bioorg. Med. Chem. Lett. 24, 262–267 (2014). · doi:10.1016/j.bmcl.2013.11.026
- Fan, Y. et al. The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach. Bioorg. Med. Chem. Lett. 18, 5789–5791 (2008). · doi:10.1016/j.bmcl.2008.09.075
- Yang, X. et al. Discovery of small molecule agonist of Gonadotropin-Releasing Hormone Receptor (GnRH1R). J. Chem. Inf. Model. 62, 5009–5022 (2022). · doi:10.1021/acs.jcim.2c00639
- Barman Balfour, J. A. & Scott, L. J. Cinacalcet hydrochloride. Drugs 65, 271–281 (2005). · doi:10.2165/00003495-200565020-00007
- Xu, X. Y. et al. Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics. Nat. Commun. 14, 2138–2150 (2023). · doi:10.1038/s41467-023-37808-y
- Akizawa, T. et al. Evocalcet: A new oral calcimimetic for dialysis patients with secondary Hyperparathyroidism. Ther. Apher. Dial. 24, 248–257 (2020). · doi:10.1111/1744-9987.13434
- Liu, F. et al. Structure-based discovery of positive allosteric modulators for the calcium sensing receptor. bioRxiv 573448 (2023).
- Mane, N., Jimenez-Sabado, V. & Jimenez, M. BPTU, an allosteric antagonist of P2Y1 receptor, blocks nerve mediated inhibitory neuromuscular responses in the gastrointestinal tract of rodents. Neuropharmacology 110, 376–385 (2016). · doi:10.1016/j.neuropharm.2016.07.033
- Zhuang, Y. W. et al. Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor. Cell Res 31, 593–596 (2021). · doi:10.1038/s41422-021-00482-0
- Sibley, D. R., Luderman, K. D., Free, R. B. & Shi, L. Novel Cryo-EM structures of the D1 dopamine receptor unlock its therapeutic potential. Signal Transduct. Target. Ther. 6, 205 (2021). · doi:10.1038/s41392-021-00630-3
- Milanos, L. et al. Discovery and characterization of biased allosteric agonists of the chemokine Receptor CXCR3. J. Med. Chem. 59, 2222–2243 (2016). · doi:10.1021/acs.jmedchem.5b01965
- Lee, D. F., Geron, M. & Scherrer, G. A modulator-bound GPCR structure enables allosteric non-opioid analgesia. Nat. Struct. Mol. Biol. 28, 871–872 (2021). · doi:10.1038/s41594-021-00681-8
- Cong, X. J. et al. Allosteric modulation mechanism of the mGIuR(5) Transmembrane domain. J. Chem. Inf. Model. 59, 2871–2878 (2019). · doi:10.1021/acs.jcim.9b00045
- Kumar, K. K. et al. Step-wise activation of a Family C GPCR. Biorxiv. https://doi.org/10.1101/2023.08.29.555158 (2023). · doi:10.1101/2023.08.29.555158
- Nishimura, Y. et al. Lead optimization and avoidance of reactive metabolite leading to PCO371, a potent, selective, and orally available human parathyroid hormone receptor 1 (hPTHR1) agonist. J. Med. Chem. 63, 5089–5099 (2020). · doi:10.1021/acs.jmedchem.9b01743
- Xiao, H., Sun, Q. & Sun, Q. A promising small molecule binding pocket in class B GPCRs: expanding potential for drug development. Signal Transduct. Target. Ther. 8, 313 (2023). · doi:10.1038/s41392-023-01598-y
- Monnier, C. et al. Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation. EMBO J. 30, 32–42 (2011). · doi:10.1038/emboj.2010.270
- Powers, A. S. et al. Structural basis of efficacy-driven ligand selectivity at GPCRs (Feb, 10.1038/s41589-022-01247-5, 2023). Nat. Chem. Biol. 19, 529–529 (2023). · doi:10.1038/s41589-023-01297-3
- Liu, H. T. et al. Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists. Proc. Natl Acad. Sci. USA 115, 12046–12050 (2018). · doi:10.1073/pnas.1813988115
- Wang, X. D. et al. Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery. Nat. Commun. 14, 1325–1334 (2023). · doi:10.1038/s41467-023-36971-6
- Aurelio, L. et al. A structure-activity relationship study of bitopic N6-substituted adenosine derivatives as biased Adenosine A1 receptor agonists. J. Med. Chem. 61, 2087–2103 (2018). · doi:10.1021/acs.jmedchem.8b00047
- Wang, X. W. et al. Structural insights into dimerization and activation of the mGlu2-mGlu3 and mGlu2-mGlu4 heterodimers. Cell Res 33, 762–774 (2023). · doi:10.1038/s41422-023-00830-2
- Li, F. H. et al. Molecular recognition and activation mechanism of short-chain fatty acid receptors FFAR2/3. Cell Res. https://doi.org/10.1038/s41422-023-00914-z (2024). · doi:10.1038/s41422-023-00914-z
Cited by
GPCRchimeraDB: A Database of Chimeric G Protein-Coupled Receptors (GPCRs) to Assist Their Design
Crauwels, C., Díaz, A., & Vranken, W. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169164 · Cited by 2
Cheng, L., Wei, T., Cui, X., Chen, H.-F., & Yu, Z. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf391 · Cited by 1
Angiotensin 1–7 Modulates the Dynamics and Activation of the Proto‐Oncogene Mas Receptor
Yasar, E., Dogru, S., Eroglu, E., & Yaras, N. (2026) · Journal of Molecular Recognition · doi:10.1002/jmr.70031 · Cited by 1
Quantitative deciphering of mammalian histamine receptors through mathematical genomics
Hassan, S. S., Nawn, D., Goswami, P., Mukherjee, N., Sil, M., Roy, S., Goswami, A., Das, S., & Uversky, V. N. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153717
Metadata
- Authors
- Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-04-10
- Volume
- 9
- Issue
- 1
- Pages
- 88-88
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4394623467
- Cited by
- 491
- References
- 454
- FWCI
- 56.93
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- National Natural Science Foundation of China (22077082)
- the Shanghai Frontiers Science Center of Cellular Homeostasis and the Human Diseases, and the Innovative Research Team of High-Level Local Universities in Shanghai
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery. https://app.cochat.ai/papers/10.1038/s41392-024-01803-6
- The paper
- Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024). G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-024-01803-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.